RBMX expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.511400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.112000E-01
Normal-vs-Stage2
3.506600E-01
Normal-vs-Stage3
1.025980E-01
Normal-vs-Stage4
4.210800E-01
Stage1-vs-Stage2
5.453200E-01
Stage1-vs-Stage3
4.198200E-02
Stage1-vs-Stage4
3.499200E-01
Stage2-vs-Stage3
7.396400E-02
Stage2-vs-Stage4
1.857790E-01
Stage3-vs-Stage4
3.089700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.534200E-01
Normal-vs-AfricanAmerican
4.281200E-01
Normal-vs-Asian
2.960200E-01
Caucasian-vs-AfricanAmerican
4.956400E-01
Caucasian-vs-Asian
2.873400E-01
AfricanAmerican-vs-Asian
1.459630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.481200E-01
Normal-vs-Female
3.571000E-01
Male-vs-Female
7.739600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.277200E-01
Normal-vs-Age(41-60Yrs)
4.072400E-01
Normal-vs-Age(61-80Yrs)
3.269000E-01
Normal-vs-Age(81-100Yrs)
3.457000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.097000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.868200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.882600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.462100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.156800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.589800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.131600E-01
Normal-vs-Daily Drinker
3.193600E-01
Normal-vs-Weekly Drinker
3.147000E-01
Normal-vs-Occasional Drinker
4.151000E-01
Normal-vs-Social Drinker
3.996800E-01
Non Drinker-vs-Daily Drinker
9.194600E-01
Non Drinker-vs-Weekly Drinker
9.848000E-01
Non Drinker-vs-Occasional Drinker
1.211030E-01
Non Drinker-vs-Social Drinker
2.158400E-01
Daily Drinker-vs-Weekly Drinker
9.187000E-01
Daily Drinker-vs-Occasional Drinker
1.715180E-01
Daily Drinker-vs-Social Drinker
2.790400E-01
Weekly Drinker-vs-Occasional Drinker
1.821010E-01
Weekly Drinker-vs-Social Drinker
2.811400E-01
Occasional Drinker-vs-Social Drinker
8.457200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.151000E-01
Normal-vs-Grade 2
6.002200E-01
Normal-vs-Grade 3
5.862200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.262800E-01
Grade 1-vs-Grade 3
4.149400E-01
Grade 1-vs-Grade 4
2.151000E-01
Grade 2-vs-Grade 3
7.025000E-01
Grade 2-vs-Grade 4
6.002200E-01
Grade 3-vs-Grade 4
5.862200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.082600E-01
Normal-vs-NonDiabetic
3.437800E-01
Diabetic-vs-NonDiabetic
2.549000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.931200E-01
Normal-vs-NoPancreatitis
3.400600E-01
Pancreatitis-vs-NoPancreatitis
3.244600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.818600E-01
Normal-vs-N1
3.418800E-01
N0-vs-N1
2.679800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.491400E-01
Normal-vs-TP53-NonMutant
4.624200E-01
TP53-Mutant-vs-TP53-NonMutant
8.132000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
